(PharmaNewsWire.Com, March 03, 2021 ) Exhaustive secondary research was conducted to collect information on the market and its different subsegments. The study involved four major activities in estimating the current market size of the China cardiology information system market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Then, both top-down and bottom-up approaches were employed to estimate the complete market size.
Key Factors Driving Market Growth:
Growth in this market is mainly driven by the increasing incidence and prevalence of cardiovascular disease, government initiatives in China, and the increasing number of hospitals.
Revenue Growth Analysis:
The China cardiology information system market is projected to reach $54 million by 2024 from $35 million in 2019, at a CAGR of 8.9% during the forecast period.
Key Questions Addressed in the Report: What are the growth opportunities offered by the market in the next five years? How will advancements in products offered by various companies affect the market scenario in the mid- to long-term? What are the trends and advancements in the China cardiology information system market? Don't miss out on business opportunities in Cardiology Information System (CIS) Market
Based on system, the market is segmented into integrated and standalone systems. The integrated systems segment is projected to witness the highest growth during the forecast period. The increasing adoption of integrated systems by healthcare providers is the major factor supporting the growth of this segment.
Browse in-depth TOC on "Cardiology Information System Market"
The software segment accounted for the largest share of the China cardiology information system market in 2018
By component, the market is segmented into software, services, and hardware. The software segment accounted for the largest market share in 2018. The large share of this segment can be attributed to the growing need to integrate CVIS with C-PACS, EMRs, and other cardiology modules.
L3A hospitals accounted for the largest share of the China cardiology information system market in 2018
Based on end user, the market is segmented into L3A hospitals and L3B & L2 Hospitals. The L3A hospitals segment accounted for the largest share of the market in 2018. The increasing number of L3A hospitals in China and growing disease prevalence are responsible for the large share of this market segment.
Key players in the China cardiology information system market are Philips Healthcare (Netherlands), CREALIFE Medical Technology (China), Central Data Network (Australia), Infinitt Healthcare (South Korea) and Esaote (Italy).
In 2018, CREALIFE Medical Technology held the leading position in the market. The company has good relations with government bodies, distributors, and hospitals in the market, which is its key strength. Philips Healthcare held the second position in the market in 2018.
Key Questions Addressed in the Report:
1. What are the growth opportunities offered by the market in the next five years? 2. How will advancements in products offered by various companies affect the market scenario in the mid- to long-term? 3. What are the trends and advancements in the China cardiology information system market?
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
